We are live on !
Find out more
TS
Third Security Portfolio holdings
AUM
$241M
Turnover
0%
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
-$11.2M
(-0.44%)
Cap. Flow
+$17.9M
Cap. Flow % of AUM
Cap. Flow %
0.71%
Top 10 Holdings %
Top 10 Hldgs %
99.02%
Holding
18
New
–
Increased
4
Reduced
–
Closed
1
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$14.4M |
| 2 |
Oragenics
OGEN
|
+$4.67M |
| 3 |
Alaunos Therapeutics
TCRT
|
+$294K |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$294K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMLP
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
|
+$1.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.59% |
| 2 | Energy | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Precigen
PGEN
$2.37B
| $1.87B | 74.88% |
62,706,627
+426,423
| +0.7% | +$14.4M |
2013 Q3
9 quarters
|
|
2
Halozyme
HALO
$14B
| $344M | 13.73% |
19,829,337
| – | – |
2013 Q2
10 quarters
|
|
|
3
Alaunos Therapeutics
TCRT
$7.82M
| $80.5M | 3.22% |
64,616
+178
| +0.3% | +$294K |
2013 Q2
10 quarters
|
|
|
FCSC
4
DELISTED
Fibrocell Science Inc.
FCSC
| $75.6M | 3.02% |
1,108,028
| – | – |
2013 Q2
10 quarters
|
|
5
Theriva Biologics
TOVX
$9.5M
| $30.3M | 1.21% |
1,513
| – | – |
2013 Q2
10 quarters
|
|
6
Enterprise Products Partners
EPD
$79.4B
| $26.5M | 1.06% |
1,035,834
| – | – |
2013 Q2
10 quarters
|
|
|
7
Oragenics
OGEN
$1.94M
| $19.8M | 0.79% |
734
+187
| +34% | +$4.67M |
2013 Q2
10 quarters
|
|
8
Energy Transfer Partners
ET
$69.6B
| $10.3M | 0.41% |
752,400
| – | – |
2013 Q2
10 quarters
|
|
9
Ocugen
OCGN
$274M
| $9.42M | 0.38% |
44,843
| – | – |
2014 Q4
4 quarters
|
|
10
Genesis Energy
GEL
$1.7B
| $7.97M | 0.32% |
217,000
| – | – |
2013 Q2
10 quarters
|
|
|
TCP
11
DELISTED
TC Pipelines LP
TCP
| $4.82M | 0.19% |
97,000
| – | – |
2013 Q2
10 quarters
|
|
12
DELISTED
NuStar Energy L.P.
NS
| $4.67M | 0.19% |
116,500
| – | – |
2013 Q2
10 quarters
|
|
13
Armata Pharmaceuticals
ARMP
$122M
| $4.61M | 0.18% |
8,277
| – | – |
2015 Q3
1 quarter
|
|
14
Tempest Therapeutics
TPST
$10.4M
| $3.65M | 0.15% |
128
| – | – |
2013 Q4
8 quarters
|
|
15
Martin Midstream Partners
MMLP
$77.9M
| $3.08M | 0.12% |
141,800
| – | – |
2013 Q2
10 quarters
|
|
|
ETP
16
DELISTED
Energy Transfer Partners L.p.
ETP
| $2.87M | 0.11% |
85,135
+7,500
| +10% | +$294K |
2015 Q2
2 quarters
|
|
17
Precipio
PRPO
$39.5M
| $824K | 0.03% |
86
| – | – |
2014 Q2
6 quarters
|
|
|
CMLP
18
DELISTED
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
| – | – |
-284,620
| Closed | -$1.76M | – |
|
Similar funds
KRC
A
AIA
FG
RFA
UIA
GCM
GMA
Third Security's Q4 2015 Portfolio in Review
As of Q4 2015, Third Security held 18 positions worth $2.5B, down 0.44% from $2.51B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Third Security's Q4 2015 filing shows 4 increased and 1 closed positions. The largest sale was CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE), an estimated $1.76M.
By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Energy.
- Third Security added most to Precigen in Q4 2015, an estimated $14.4M increase.
- Third Security fully exited CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE) in Q4 2015, selling an estimated $1.76M.
- Third Security's ten largest holdings make up 99% of its $2.5B portfolio in Q4 2015.
- Third Security opened 0 new positions and closed 1 in Q4 2015.
- Third Security's portfolio value fell 0.44% quarter-over-quarter to $2.5B.
Based on Third Security's 13F filing for Q4 2015, filed 1 Feb 2016.